Confirming what many, if not all providers in healthcare delivery already know, a study in the Annals of Int. Med. confirms the rampant favorability of results in pharma industry sponsored trials. In the meta analysis of over 500 trials, researchers found that industry-funded trials received positive outcomes approx. 80 percent of the time, compared to positive outcomes in just 50 percent of government-funded ones. Also, results of industry-funded studies were published within two years of study completion 32 percent of the time compared with 54 percent for government trials — suggesting not only certain bias in reporting in heavily invested outcomes, but also that government funding occurs sooner in trails when results may not seem as certain to produce a favorable outcome. The government’s registry of trials in development provides excellent information on study quality of over 90,000 investigations for those interested in getting at the true purpose of a proposed clinical trial. | LINK

Related Posts Within Doctor Pundit:

1. Study Evaluation Group Offers Results on the Nature of Medical Studies with Positive Results The Cochrane Collaboration, an international body which evaluates published medical...
2. Study: Vioxx Risk of Death Known Almost Three Years Before Market Withdrawal Pharma company Merck withdrew the popular anti-inflammatory agent Vioxx (rofecoxib)...
3. Study: Screening Mammograms Underutilized in Insured Women With research findings such as this, is it any wonder...
4. CMS Releases Annual Healthcare Spending Report with Unsurprising Results The effect of the Great Recession spared no sector, including...
5. Audit: African-Americans Less Likely to Receive Study Grants I have a hard time taking in this news item....